Our scientists and doctors developed a combination of medicines to deprive cancer of the nutrients it needs to grow and spread
*Care Oncology U.S. works in coordination with the SEEK Group and Care Oncology Clinic of London, UK
*COC Protocol Doubles Patient Survival
Treatment now available in the U.S.
Our FDA Approved Medications are cost effective, safe, well tolerated and well understood
Upcoming Cancer Trials
If you are interested in the COC Cancer Protocol or upcoming Cancer Trials - Join Now
Scientists have spent in excess of 5 years working on the best combination of medicines to use to target the metabolic pathways of cancer that are safe and work in harmony with standard of care cancer treatments. This involved cellular and animal experiments in the laboratory as well as literature research of existing medicines looking at the way they work and their safety profile as well as those that have shown significant benefit in a large number of humans with cancer or as a preventative to cancer.
GLIOBLASTOMA SURVIVABILITY DOUBLES WITH COC PHARMACEUTICAL COMPOSITION
Care Oncology’s patented COC Protocol™ has proven to increase the survival in Glioblastoma patients when used in combination with standard-of-care*.
A clinical trial performed in the U.K., comprised of a 95-patient cohort, resulted in a median overall survival of 27 months when the COC Protocol was used in addition to standard-of-care. Compared to median overall survival of 15.6 months¹ and 14.8 months² with standard-of-care alone.
See long term Glioblastoma survivors in the news who use the COC Protocol:
Patient 1 now 4 years out post diagnosis – Featured in The Telegraph
Patient 2 now 3 years out post diagnosis – Featured in Daily Mail
The Care Oncology Clinic designed the COC Protocol to complement and enhance standard-of-care therapy.
Our 4-year study has shown that our adjunctive program may enhance the overall effect of conventional cancer treatment.